Current Report Filing (8-k)
09 September 2021 - 4:32AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM
8-K
CURRENT
REPORT
Pursuant
to Section 13 or 15(d) of the
Securities
Exchange Act of 1934
Date
of report (Date of earliest event reported): August 13, 2021
KYTO
TECHNOLOGY AND LIFE SCIENCE, INC.
(Exact
Name of Registrant as Specified in Charter)
Delaware
|
|
000-50390
|
|
65-108-6538
|
(State
or Other Jurisdiction
of
Incorporation)
|
|
(Commission
File
Number)
|
|
(I.R.S.
Employer
Identification
No.)
|
13050
La Paloma Road, Los Altos Hills, CA 94022
(Address
of Principal Executive Offices, and Zip Code)
650-204-7896
Registrant’s
Telephone Number, Including Area Code
Not
Applicable
(Former
Name or Former Address, if Changed Since Last Report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions (see General Instruction A.2. below):
|
☐
|
Written
communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
|
☐
|
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
|
☐
|
Pre-commencement
communication pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
|
☐
|
Pre-commencement
communication pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Securities
registered pursuant to Section 12(b) of the Act:
Title
of each class
|
|
Trading
Symbol(s)
|
|
Name
of each exchange on which registered
|
N/A
|
|
N/A
|
|
N/A
|
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2 of this chapter).
Emerging
growth company ☐
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item
3.02.Unregistered Sales of Equity Securities.
On
September 1, 2021, Kyto Technology & Life Sciences, Inc. (the “Company”) issued 262,500 shares of the Company’s
Class B1 Preferred Stock (the “Class B1 Shares”) at a purchase price of $0.80 per share, resulting in aggregate proceeds
to the Company of $210,000.
The
foregoing issuances were exempt from the registration requirements of the Securities Act of 1933, as amended, pursuant to Section 4(a)(2)
thereof as a transaction by an issuer not involving a public offering.
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
|
KYTO
TECHNOLOGY AND LIFE SCIENCE, INC.
|
|
|
|
Date:
September 8, 2021
|
By:
|
/s/
Paul Russo
|
|
|
Paul
Russo
Chief
Executive Officer
|
Kyto Technology and Life... (CE) (USOTC:KBPH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Kyto Technology and Life... (CE) (USOTC:KBPH)
Historical Stock Chart
From Sep 2023 to Sep 2024